Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Stereochemistry of Linoleic Acid Esters of Hydroxy Linoleic Acids.

Wang H, Kolar MJ, Chang T, Rizo J, Konduri S, McNerlin C, Saghatelian A, Siegel D.

Org Lett. 2019 Oct 4;21(19):8080-8084. doi: 10.1021/acs.orglett.9b03054. Epub 2019 Sep 23.

PMID:
31545060
2.

Racial Disparity Among Women Diagnosed With Invasive Breast Cancer in a Large Integrated Health System.

Singh M, Konduri SD, Bobustuc GC, Kassam AB, Rovin RA.

J Patient Cent Res Rev. 2018 Jul 30;5(3):218-228. doi: 10.17294/2330-0698.1621. eCollection 2018 Summer.

3.

Linoleic acid esters of hydroxy linoleic acids are anti-inflammatory lipids found in plants and mammals.

Kolar MJ, Konduri S, Chang T, Wang H, McNerlin C, Ohlsson L, Härröd M, Siegel D, Saghatelian A.

J Biol Chem. 2019 Jul 5;294(27):10698-10707. doi: 10.1074/jbc.RA118.006956. Epub 2019 May 31.

PMID:
31152059
4.

Discovery of FAHFA-Containing Triacylglycerols and Their Metabolic Regulation.

Tan D, Ertunc ME, Konduri S, Zhang J, Pinto AM, Chu Q, Kahn BB, Siegel D, Saghatelian A.

J Am Chem Soc. 2019 Jun 5;141(22):8798-8806. doi: 10.1021/jacs.9b00045. Epub 2019 May 13.

PMID:
31056915
5.

TP53 Status as a Determinant of Pro- versus Anti-tumorigenic Effects of Estrogen Receptor-beta in Breast Cancer.

Mukhopadhyay UK, Oturkar CC, Adams C, Wickramasekera N, Bansal S, Medisetty R, Miller A, Swetzig WM, Silwal-Pandit L, Borresen-Dale AL, Creighton CJ, Park JH, Konduri SD, Mukhopadhyay A, Caradori A, Omilian A, Bshara W, Kaipparettu BA, Das GM.

J Natl Cancer Inst. 2019 Apr 16. pii: djz051. doi: 10.1093/jnci/djz051. [Epub ahead of print]

PMID:
30990221
6.

Synthesis of chemically edited derivatives of the endogenous regulator of inflammation 9-PAHSA.

Wang H, Chang T, Konduri S, Huang J, Saghatelian A, Siegel D.

J Antibiot (Tokyo). 2019 Jun;72(6):498-506. doi: 10.1038/s41429-019-0180-1. Epub 2019 Apr 15.

PMID:
30988370
7.

MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to temozolomide.

Bobustuc GC, Kassam AB, Rovin RA, Jeudy S, Smith JS, Isley B, Singh M, Paranjpe A, Srivenugopal KS, Konduri SD.

Oncotarget. 2018 Jul 3;9(51):29727-29742. doi: 10.18632/oncotarget.25696. eCollection 2018 Jul 3.

8.

New insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy.

Paranjpe A, Bailey NI, Konduri S, Bobustuc GC, Ali-Osman F, Yusuf MA, Punganuru SR, Madala HR, Basak D, Mostofa A, Srivenugopal KS.

J Biomed Res. 2016 Sep;30(5):393-410. doi: 10.7555/JBR.30.20160040. Epub 2016 Jun 10.

9.

MGMT inhibition suppresses survivin expression in pancreatic cancer.

Bobustuc GC, Patel A, Thompson M, Srivenugopal KS, Frick J, Weese J, Konduri SD.

Pancreas. 2015 May;44(4):626-35. doi: 10.1097/MPA.0000000000000299.

PMID:
25875800
10.

MGMT inhibition restores ERα functional sensitivity to antiestrogen therapy.

Bobustuc GC, Smith JS, Maddipatla S, Jeudy S, Limaye A, Isley B, Caparas ML, Constantino SM, Shah N, Baker CH, Srivenugopal KS, Baidas S, Konduri SD.

Mol Med. 2012 Sep 7;18:913-29. doi: 10.2119/molmed.2012.00010. Erratum in: Mol Med. 2012;18: doi/10.2119/molmed.2012.00006.erratum.

11.

Blockade of MUC1 expression by glycerol guaiacolate inhibits proliferation of human breast cancer cells.

Smith JS, Colon J, Madero-Visbal R, Isley B, Konduri SD, Baker CH.

Anticancer Agents Med Chem. 2010 Oct 1;10(8):644-6650.

PMID:
21184665
12.

Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.

Konduri SD, Medisetty R, Liu W, Kaipparettu BA, Srivastava P, Brauch H, Fritz P, Swetzig WM, Gardner AE, Khan SA, Das GM.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15081-6. doi: 10.1073/pnas.1009575107. Epub 2010 Aug 9.

13.

Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide.

Bobustuc GC, Baker CH, Limaye A, Jenkins WD, Pearl G, Avgeropoulos NG, Konduri SD.

Neuro Oncol. 2010 Sep;12(9):917-27. doi: 10.1093/neuonc/noq044. Epub 2010 Jun 4.

14.

Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation.

Schwarz RE, Awasthi N, Konduri S, Caldwell L, Cafasso D, Schwarz MA.

Cancer Biol Ther. 2010 Apr 15;9(8):632-9. Epub 2010 Apr 20.

PMID:
20212356
15.

EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer.

Schwarz RE, Awasthi N, Konduri S, Cafasso D, Schwarz MA.

Ann Surg Oncol. 2010 May;17(5):1442-52. doi: 10.1245/s10434-009-0879-5. Epub 2009 Dec 30.

PMID:
20041350
16.

Angiogenesis: an update and potential drug approaches (review).

Abdelrahim M, Konduri S, Basha R, Philip PA, Baker CH.

Int J Oncol. 2010 Jan;36(1):5-18. Review.

PMID:
19956828
17.

Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice.

Colon J, Basha MR, Madero-Visbal R, Konduri S, Baker CH, Herrera LJ, Safe S, Sheikh-Hamad D, Abudayyeh A, Alvarado B, Abdelrahim M.

Invest New Drugs. 2011 Feb;29(1):41-51. doi: 10.1007/s10637-009-9331-8. Epub 2009 Oct 23.

PMID:
19851711
18.

Blockade of MGMT expression by O6 benzyl guanine leads to inhibition of pancreatic cancer growth and induction of apoptosis.

Konduri SD, Ticku J, Bobustuc GC, Sutphin RM, Colon J, Isley B, Bhakat KK, Srivenugopal KS, Baker CH.

Clin Cancer Res. 2009 Oct 1;15(19):6087-95. doi: 10.1158/1078-0432.CCR-09-0887. Epub 2009 Sep 29. Erratum in: Clin Cancer Res. 2010 Jan 1;16(1):369. Kalkunte, Srivenugopal S [corrected to Srivenugopal, Kalkunte S].

19.

An antiendothelial combination therapy strategy to increase survival in experimental pancreatic cancer.

Schwarz RE, Konduri S, Awasthi N, Cafasso D, Schwarz MA.

Surgery. 2009 Aug;146(2):241-9. doi: 10.1016/j.surg.2009.04.015.

PMID:
19628080
20.

Self-diffusion of water and simple alcohols in single-walled aluminosilicate nanotubes.

Zang J, Konduri S, Nair S, Sholl DS.

ACS Nano. 2009 Jun 23;3(6):1548-56. doi: 10.1021/nn9001837.

PMID:
19545168
21.

Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.

Konduri S, Colon J, Baker CH, Safe S, Abbruzzese JL, Abudayyeh A, Basha MR, Abdelrahim M.

Mol Cancer Ther. 2009 Mar;8(3):533-42. doi: 10.1158/1535-7163.MCT-08-0405. Epub 2009 Mar 3.

22.

Estrogen-mediated downregulation of CD24 in breast cancer cells.

Kaipparettu BA, Malik S, Konduri SD, Liu W, Rokavec M, van der Kuip H, Hoppe R, Hammerich-Hille S, Fritz P, Schroth W, Abele I, Das GM, Oesterreich S, Brauch H.

Int J Cancer. 2008 Jul 1;123(1):66-72. doi: 10.1002/ijc.23480. Erratum in: Int J Cancer. 2019 Nov 15;145(10):E21.

23.

Controlling nanotube dimensions: correlation between composition, diameter, and internal energy of single-walled mixed oxide nanotubes.

Konduri S, Mukherjee S, Nair S.

ACS Nano. 2007 Dec;1(5):393-402. doi: 10.1021/nn700104e.

PMID:
19206659
24.

Pulmonary hypertension caused by metastatic breast cancer and its response to antihormone therapy and chemotherapy.

Konduri S, Khan Q, Stites S.

Breast J. 2007 Sep-Oct;13(5):506-8. No abstract available.

PMID:
17760674
25.

Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.

Sayeed A, Konduri SD, Liu W, Bansal S, Li F, Das GM.

Cancer Res. 2007 Aug 15;67(16):7746-55.

26.

Androgen receptor blockade in experimental combination therapy of pancreatic cancer.

Konduri S, Schwarz MA, Cafasso D, Schwarz RE.

J Surg Res. 2007 Oct;142(2):378-86. Epub 2007 Jun 7.

PMID:
17559882
27.

Estrogen receptor beta/alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens.

Konduri S, Schwarz RE.

J Surg Res. 2007 Jun 1;140(1):55-66. Epub 2007 Feb 1.

PMID:
17275032
28.

An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch.

Balachandran K, Konduri S, Sucosky P, Jo H, Yoganathan AP.

Ann Biomed Eng. 2006 Nov;34(11):1655-65. Epub 2006 Oct 10.

29.

Cyclic aortic pressure affects the biological properties of porcine pulmonary valve leaflets.

Ikhumetse JD, Konduri S, Warnock JN, Xing Y, Yoganathand AP.

J Heart Valve Dis. 2006 Mar;15(2):295-302.

PMID:
16607914
30.

Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function.

Liu W, Konduri SD, Bansal S, Nayak BK, Rajasekaran SA, Karuppayil SM, Rajasekaran AK, Das GM.

J Biol Chem. 2006 Apr 14;281(15):9837-40. Epub 2006 Feb 9.

31.

Design of a sterile organ culture system for the ex vivo study of aortic heart valves.

Warnock JN, Konduri S, He Z, Yoganathan AP.

J Biomech Eng. 2005 Oct;127(5):857-61.

PMID:
16248316
32.

Normal physiological conditions maintain the biological characteristics of porcine aortic heart valves: an ex vivo organ culture study.

Konduri S, Xing Y, Warnock JN, He Z, Yoganathan AP.

Ann Biomed Eng. 2005 Sep;33(9):1158-66.

PMID:
16133923
33.

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.

Oncogene. 2003 Jul 17;22(29):4509-16.

PMID:
12881707
34.

Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells.

Yanamandra N, Berhow MA, Konduri S, Dinh DH, Olivero WC, Nicolson GL, Rao JS.

Clin Exp Metastasis. 2003;20(4):375-83.

PMID:
12856725
35.

Physiological and chemical inducers of tissue factor pathway inhibitor-2 in human glioma cells.

Konduri SD, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Rao JS.

Int J Oncol. 2003 Jun;22(6):1277-83.

PMID:
12738994
36.

Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells.

Konduri SD, Yanamandra N, Siddique K, Joseph A, Dinh DH, Olivero WC, Gujrati M, Kouraklis G, Swaroop A, Kyritsis AP, Rao JS.

Oncogene. 2002 Dec 12;21(57):8705-12.

37.

Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.

Konduri SD, Osman FA, Rao CN, Srinivas H, Yanamandra N, Tasiou A, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Kouraklis G, Rao JS.

Oncogene. 2002 Jan 31;21(6):921-8.

38.

Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells.

Yanamandra N, Konduri SD, Mohanam S, Dinh DH, Olivero WC, Gujrati M, Nicolson GL, Obeyeseke M, Rao JS.

Clin Exp Metastasis. 2000;18(7):611-5.

PMID:
11688967
39.

A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.

Konduri SD, Rao CN, Chandrasekar N, Tasiou A, Mohanam S, Kin Y, Lakka SS, Dinh D, Olivero WC, Gujrati M, Foster DC, Kisiel W, Rao JS.

Oncogene. 2001 Oct 18;20(47):6938-45.

40.

A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas.

Tasiou A, Konduri SD, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Obeyesekere M, Rao JS.

Int J Oncol. 2001 Sep;19(3):591-7.

PMID:
11494041
41.

Elevated levels of cathepsin B in human glioblastoma cell lines.

Konduri S, Lakka SS, Tasiou A, Yanamandra N, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao JS.

Int J Oncol. 2001 Sep;19(3):519-24.

PMID:
11494030
42.

Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion.

Konduri SD, Tasiou A, Chandrasekar N, Nicolson GL, Rao JS.

Clin Exp Metastasis. 2000;18(4):303-8.

PMID:
11448060
43.

In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2.

Lakka SS, Konduri SD, Mohanam S, Nicolson GL, Rao JS.

Clin Exp Metastasis. 2000;18(3):239-44.

PMID:
11315097
44.

Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.

Rao CN, Lakka SS, Kin Y, Konduri SD, Fuller GN, Mohanam S, Rao JS.

Clin Cancer Res. 2001 Mar;7(3):570-6.

45.

Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro.

Konduri SD, Tasiou A, Chandrasekar N, Rao JS.

Int J Oncol. 2001 Jan;18(1):127-31.

PMID:
11115549
46.

Effects of radiation on the levels of MMP-2, MMP-9 and TIMP-1 during morphogenic glial-endothelial cell interactions.

Nirmala C, Jasti SL, Sawaya R, Kyritsis AP, Konduri SD, Ali-Osman F, Rao JS, Mohanam S.

Int J Cancer. 2000 Dec 1;88(5):766-71.

Supplemental Content

Loading ...
Support Center